LIFE
METER
.XYZ
Calibrate
LEV Preparedness
Bio Age
Expanded BioAge Survey
Biomarker Trend Analyzer
Invisible Age
Functional Resilience
Wearable Synthesis
Command Center
Survive
LEV Bridge
Insolvency
Medical Black Swan
Extreme Inflation
Singularity Sequence
Command Center
Analyze
The Independence Horizon
Global Data Atlas
Mismatch Analyzer
Sync Paradox
Global LEV Index
Command Center
Learn
1. Bridge Strategy
2. LEV Primer
3. The Death Gap
4. Financial Planning
5. Biomarkers
Command Center
Reports
Longevity Evidence Briefs
2026 Longevity Horizon Report
Biomarker Essentials Guide
Premium Biomarker Mastery Guide
Strategic Intelligence Hub
Command Center
Longform
Longform Hub
Ketones and Longevity: Fuel, Signal, or Both?
DNA Methylation Drift: Cause or Consequence of Aging?
Longevity Clinics: Science, Protocols, and Variability
Is Aging a Disease or an Adaptive Program?
AI-Designed Longevity Drugs: Early Successes and Limits
Caloric Restriction Mimetics: What Actually Works in Humans
Partial Cellular Reprogramming: Reset Without Cancer Risk?
Regulatory Barriers to Anti-Aging Drugs
Longevity Escape Velocity: Realistic or Misleading?
Digital Twins for Aging: Predictive Biology at Scale
Extracellular Matrix Aging: The Forgotten Target
Senomorphics vs Senolytics: Slowing vs Removing Damage
Metformin as a Longevity Drug: Evidence vs Assumption
Yamanaka Factors in Vivo: Progress and Constraints
NAD+ Restoration: Mechanism, Hype, and Clinical Signal
Stem Cell Exhaustion and Replenishment Strategies
Hallmarks of Aging Revisited: What Changed Since 2013
Alzheimer Biomarkers Are Moving Faster Than Alzheimer Drugs
Do Multivitamins Slow Biological Aging? What the New COSMOS Clock Trial Shows, and What It Does Not
The Primary-Care Alzheimer's Pivot: What Blood Biomarkers Can and Cannot Do
Oral GLP-1 Enters Phase 3 Reality: Convenience, Adherence, and Longevity Tradeoffs
Intermittent Fasting After the Hype Cycle: What the 2026 Evidence Actually Supports
The 2026 Dyslipidemia Rewrite: Lp(a), ApoB, and 30-Year Risk in Preventive Longevity
GLP-1 Beyond Type 2 Diabetes: Cardiorenal Signals, Safety Boundaries, and Off-Label Drift
Epigenetic Reprogramming Enters Human Trials
AI-Accelerated Drug Discovery in Aging: Real Compression, Real Bottlenecks
Senolytics Moving into Clinical Translation
GLP-1 Drugs as Potential Longevity Agents
AI + Systems Biology for Biological Age Clocks
GLP-1 and Functional Age: When Weight Loss Helps Longevity and When It Hurts
Biological Age Clocks as Decision Tools: What Is Real, What Is Overstated, and How to Use Them Without Self-Deception
Did AI Reverse Aging? What Is Real, What Is Overstated, and What Comes Next
One Injection vs Lifetime Statins: What the CRISPR Cholesterol Trial Actually Shows
The Alzheimer’s Blood Test Era Has Started: What Changes for Patients and Primary Care?
WealthMeter
The Independence Horizon
🇺🇸
United States
WHO Baseline
LEV Future
Projected Lifespan
--
HEALTHY
DECLINE
LEV
BIRTH
AGE 100
--
Healthy Independence
--
Years in Decline
--
LEV Extension